Literature DB >> 23985681

APOBEC3B mutagenesis in cancer.

Kawai J Kuong, Lawrence A Loeb.   

Abstract

Recent evidence has implicated APOBEC3B as a source of mutations in cervical, bladder, lung, head and neck, and breast cancers. APOBEC enzymes normally function in innate immune responses, including those that target retroviruses, suggesting links between mutagenesis, immunity and viral infection in the process of cancer development.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23985681      PMCID： PMC3965181          DOI： 10.1038/ng.2736

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


  15 in total

Review 1.  Retroviral restriction by APOBEC proteins.

Authors:  Reuben S Harris; Mark T Liddament
Journal:  Nat Rev Immunol       Date:  2004-11       Impact factor: 53.106

Review 2.  Chromosome translocation, B cell lymphoma, and activation-induced cytidine deaminase.

Authors:  Davide F Robbiani; Michel C Nussenzweig
Journal:  Annu Rev Pathol       Date:  2012-09-04       Impact factor: 23.472

3.  Evidence for APOBEC3B mutagenesis in multiple human cancers.

Authors:  Michael B Burns; Nuri A Temiz; Reuben S Harris
Journal:  Nat Genet       Date:  2013-07-14       Impact factor: 38.330

Review 4.  The mutator phenotype in cancer: molecular mechanisms and targeting strategies.

Authors:  Marc J Prindle; Edward J Fox; Lawrence A Loeb
Journal:  Curr Drug Targets       Date:  2010-10       Impact factor: 3.465

5.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

6.  Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals.

Authors:  S Yamanaka; M E Balestra; L D Ferrell; J Fan; K S Arnold; S Taylor; J M Taylor; T L Innerarity
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

7.  Mutational processes molding the genomes of 21 breast cancers.

Authors:  Serena Nik-Zainal; Ludmil B Alexandrov; David C Wedge; Peter Van Loo; Christopher D Greenman; Keiran Raine; David Jones; Jonathan Hinton; John Marshall; Lucy A Stebbings; Andrew Menzies; Sancha Martin; Kenric Leung; Lina Chen; Catherine Leroy; Manasa Ramakrishna; Richard Rance; King Wai Lau; Laura J Mudie; Ignacio Varela; David J McBride; Graham R Bignell; Susanna L Cooke; Adam Shlien; John Gamble; Ian Whitmore; Mark Maddison; Patrick S Tarpey; Helen R Davies; Elli Papaemmanuil; Philip J Stephens; Stuart McLaren; Adam P Butler; Jon W Teague; Göran Jönsson; Judy E Garber; Daniel Silver; Penelope Miron; Aquila Fatima; Sandrine Boyault; Anita Langerød; Andrew Tutt; John W M Martens; Samuel A J R Aparicio; Åke Borg; Anne Vincent Salomon; Gilles Thomas; Anne-Lise Børresen-Dale; Andrea L Richardson; Michael S Neuberger; P Andrew Futreal; Peter J Campbell; Michael R Stratton
Journal:  Cell       Date:  2012-05-17       Impact factor: 41.582

8.  AID/APOBEC cytosine deaminase induces genome-wide kataegis.

Authors:  Artem G Lada; Alok Dhar; Robert J Boissy; Masayuki Hirano; Aleksandr A Rubel; Igor B Rogozin; Youri I Pavlov
Journal:  Biol Direct       Date:  2012-12-18       Impact factor: 4.540

9.  DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis.

Authors:  Benjamin Jm Taylor; Serena Nik-Zainal; Yee Ling Wu; Lucy A Stebbings; Keiran Raine; Peter J Campbell; Cristina Rada; Michael R Stratton; Michael S Neuberger
Journal:  Elife       Date:  2013-04-16       Impact factor: 8.140

10.  Mutational heterogeneity in cancer and the search for new cancer-associated genes.

Authors:  Michael S Lawrence; Petar Stojanov; Paz Polak; Gregory V Kryukov; Kristian Cibulskis; Andrey Sivachenko; Scott L Carter; Chip Stewart; Craig H Mermel; Steven A Roberts; Adam Kiezun; Peter S Hammerman; Aaron McKenna; Yotam Drier; Lihua Zou; Alex H Ramos; Trevor J Pugh; Nicolas Stransky; Elena Helman; Jaegil Kim; Carrie Sougnez; Lauren Ambrogio; Elizabeth Nickerson; Erica Shefler; Maria L Cortés; Daniel Auclair; Gordon Saksena; Douglas Voet; Michael Noble; Daniel DiCara; Pei Lin; Lee Lichtenstein; David I Heiman; Timothy Fennell; Marcin Imielinski; Bryan Hernandez; Eran Hodis; Sylvan Baca; Austin M Dulak; Jens Lohr; Dan-Avi Landau; Catherine J Wu; Jorge Melendez-Zajgla; Alfredo Hidalgo-Miranda; Amnon Koren; Steven A McCarroll; Jaume Mora; Brian Crompton; Robert Onofrio; Melissa Parkin; Wendy Winckler; Kristin Ardlie; Stacey B Gabriel; Charles W M Roberts; Jaclyn A Biegel; Kimberly Stegmaier; Adam J Bass; Levi A Garraway; Matthew Meyerson; Todd R Golub; Dmitry A Gordenin; Shamil Sunyaev; Eric S Lander; Gad Getz
Journal:  Nature       Date:  2013-06-16       Impact factor: 49.962
View more
  50 in total

1.  Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.

Authors:  Fumiaki Ito; Yang Fu; Shen-Chi A Kao; Hanjing Yang; Xiaojiang S Chen
Journal:  J Mol Biol       Date:  2017-05-04       Impact factor: 5.469

Review 2.  Functions and Malfunctions of Mammalian DNA-Cytosine Deaminases.

Authors:  Sachini U Siriwardena; Kang Chen; Ashok S Bhagwat
Journal:  Chem Rev       Date:  2016-09-01       Impact factor: 60.622

Review 3.  How the environment shapes cancer genomes.

Authors:  Gerd P Pfeifer
Journal:  Curr Opin Oncol       Date:  2015-01       Impact factor: 3.645

4.  Activation of DNA damage repair factors in HPV positive oropharyngeal cancers.

Authors:  Takeyuki Kono; Paul Hoover; Kate Poropatich; Tatjana Paunesku; Bharat B Mittal; Sandeep Samant; Laimonis A Laimins
Journal:  Virology       Date:  2020-05-22       Impact factor: 3.616

5.  Effect of apolipoprotein B mRNA-editing catalytic polypeptide-like protein-3G in cervical cancer.

Authors:  Yanhua Xu; Junhong Leng; Fang Xue; Ruiqian Dong
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

6.  APOBEC3B expression in human leptomeninges and meningiomas.

Authors:  Mahlon D Johnson; Jay E Reeder; Mary O'Connell
Journal:  Oncol Lett       Date:  2016-11-10       Impact factor: 2.967

7.  Biochemical Characterization of APOBEC3H Variants: Implications for Their HIV-1 Restriction Activity and mC Modification.

Authors:  Jiang Gu; Qihan Chen; Xiao Xiao; Fumiaki Ito; Aaron Wolfe; Xiaojiang S Chen
Journal:  J Mol Biol       Date:  2016-08-14       Impact factor: 5.469

8.  APOBEC3 deletion polymorphism is associated with epithelial ovarian cancer risk among Chinese women.

Authors:  Guannan Qi; Huijuan Xiong; Changju Zhou
Journal:  Tumour Biol       Date:  2014-02-28

9.  Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway.

Authors:  Maolan Li; Zhou Zhang; Xiaoguang Li; Junyi Ye; Xiangsong Wu; Zhujun Tan; Chang Liu; Baiyong Shen; Xu-An Wang; Wenguang Wu; Daizhan Zhou; Di Zhang; Ting Wang; Bingya Liu; Kai Qu; Qichen Ding; Hao Weng; Qian Ding; Jiasheng Mu; Yijun Shu; Runfa Bao; Yang Cao; Peizhan Chen; Tianyu Liu; Lin Jiang; Yunping Hu; Ping Dong; Jun Gu; Wei Lu; Weibin Shi; Jianhua Lu; Wei Gong; Zhaohui Tang; Yong Zhang; Xuefeng Wang; Y Eugene Chin; Xiaoling Weng; Hong Zhang; Wei Tang; Yonglan Zheng; Lin He; Hui Wang; Yun Liu; Yingbin Liu
Journal:  Nat Genet       Date:  2014-07-06       Impact factor: 38.330

10.  Correlation of APOBEC3 in tumor tissues with clinico-pathological features and survival from hepatocellular carcinoma after curative hepatectomy.

Authors:  Zongguo Yang; Yunfei Lu; Qingnian Xu; Liping Zhuang; Bozong Tang; Xiaorong Chen
Journal:  Int J Clin Exp Med       Date:  2015-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.